The Clinical Neuropsychologist

The Clinical Neuropsychologist

Published by Taylor & Francis

Online ISSN: 1744-4144

·

Print ISSN: 1385-4046

Journal websiteAuthor guidelines

Top-read articles

34 reads in the past 30 days

Figure 1. Map of spain. The blue color indicates the recruitment regions of the participants.
raw data corrected by educational level for each individual item of CCas-s.
Validation of the Spanish version of the cerebellar cognitive-affective syndrome scale

April 2025

·

36 Reads

Carmen Serrano-Munuera

·

·

Eva María Martínez Fernández

·

[...]

·

Download

Aims and scope


The Clinical Neuropsychologist publishes research, discussions and case studies on neuropsychology.

  • The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology.
  • Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers (e.g., introduction of a disorder that is typically not under the purview of clinical neuropsychology, yet presents with neurocognitive sequelae; introduction of new assessment or intervention tools)...

For a full list of the subject areas this journal covers, please visit the journal website.

Recent articles


The business of neuropsychology: Creating professional parity and financial viability when working with psychometrists
  • Literature Review

May 2025

·

1 Read




Figure 1. performance on neuropsychological tests at T1 and T2 per cognitive domain. Note: sample sizes per neuropsychological test -MoCa T1:46, T2:46; raVlT imm. T1:46, T2:45; raVlT del. T1:46, T2:45; DsF T1:46, T2:45; DsB T1:46, T2:45; stroop 3 T1:45, T2:45; stroop 3|2 T1:45, T2:45; TMT B T1:45, T2:44; TMT B|a T1:45, T2:44; CoWaT T1:46, T2:45; stroop 1 T1:46, T2:45; stroop 2 T1:46, T2:45; TMT a T1:46, T2:45; Categoric fluency T1:46, T2:45. abbreviations: MoCa: Montreal Cognitive assessment; raVlT imm.: rey's auditory Verbal learning Test immediate recall; raVlT del.: rey's auditory Verbal learning Test delayed recall; DsF: Digit span Forward; DsB: Digit span Backward; TMT: Trailmaking Test; CoWaT: Controlled oral Word association Test.
Long-term cognitive functioning following COVID-19: Negligible neuropsychological changes over time
  • Article
  • Full-text available

May 2025

·

29 Reads

Objective: Objective cognitive impairment has been shown in a minority of hospitalized COVID-19 patients, and longitudinal studies with a relatively long follow-up duration are scarce. We sought to investigate the presence and long-term change of objectivecognitive functioning. Method: Forty-six initially hospitalized (18 ± 19 days) COVID-19 survivors (male/female: 30/16; age: 61 ± 11) underwent extensive neuropsychological assessment (including performance validity) approximately 1 (T1) and 2.5 years (T2) post-infection. Cognitive domains assessed were: memory, attention, executive functioning, processing speed, and language (n = 14(sub)tests). We used normative data to derive age, sex, and education-adjusted T-scores (T ≤ 35 [≤–1.5SD], deficit cut-off). Repeated measures AN(C)OVAs were used to investigate cognitivefunctioning over time. Results: Mean neuropsychological performance (n = 14 tests) was within normal range at both timepoints, and number of individuals with objective cognitive deficits ranged from 0–20% (T1), and 2–22% (T2). Number of subjective cognitive complaints remained unchanged. A minority (17%) showed objective cognitive deficits on ≥2 tests at both 1 and 2.5 years post-infection, but not consistently within one cognitive domain. Longitudinal analyses on the total sample showed improvement inperformance over time on phonemic fluency (p<.001), but stable cognitive performance on all other tests, independent of prior comorbidities, subjective cognitive complaints, depressive symptoms, and ICU admission. Conclusions: There were no consistent objective cognitive deficits or major cognitive disorders years after SARS-CoV-2 infection in the majority of cases. Neuropsychological functioning remained essentially unchanged over time. Future larger longitudinal studies are necessary to unravel COVID-19-related cognitive phenotypes of persisting deficits and how these can be modulated.












Tracking the norms: A regression-based approach to trail making test performance in the Turkish population

March 2025

·

19 Reads

Objective: The Trail Making Test (TMT) is a widely used neuropsy-chological tool for assessing executive functions. This study aimed to establish regression-based normative data for TMT performance in a Turkish population aged 18-80, accounting for the effects of age, education, and sex on both basic (TMT A and TMT B) and derived scores (TMT B-A and TMT B/A). Method: A total of 462 participants were recruited, with 409 included in the final analysis after applying exclusion criteria. Participants completed the international version of the TMT. Pearson correlation analyses and multiple linear regression models assessed relationships between TMT scores and demographic variables. Education was treated as a continuous variable, and regression-based norms were developed for all TMT scores. Results: Age and education were significant predic-tors of TMT performance. Age primarily affected TMT A scores, while education was the strongest predictor for TMT B, TMT B-A, and TMT B/A scores. The regression models explained 36-38% of the variance in basic scores and 6-24% in derived scores. Women performed better than men on the TMT B/A ratio score, but overall , sex had a less pronounced effect than age and education. Conclusions: This study provides the first regression-based norma-tive data for the TMT in a Turkish population. These norms are crucial for improving the accuracy of neuropsychological assessments in Turkey and facilitating cross-cultural comparisons in cognitive research. The findings emphasize the importance of adjusting for demographic factors in clinical and research settings to ensure precise evaluations of cognitive functioning.












Journal metrics


3.0 (2023)

Journal Impact Factor™


29%

Acceptance rate


8.4 (2023)

CiteScore™


23 days

Submission to first decision


12 days

Acceptance to publication


1.613 (2023)

SNIP


1.310 (2023)

SJR

Editors